RxDoctor Payments Data

Richard Wagner, PA

Physician Assistant · Tulsa, OKNPI 1326405879

Payments from drug & device makers

$2,967in general payments, 2019–2025

Across 154 payments — averaging $19.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$420
  • Alkermes, Inc.$395
  • Indivior Inc.$393
  • Otsuka America Pharmaceutical, Inc.$376
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$260
  • Vanda Pharmaceuticals Inc.$253
  • plus $870 from 6 others

What the payments were for

  • Food & beverage$2,967100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,967 in reported general payments places this provider in the 85th percentile of 1,491 physician assistant providers in Oklahoma.

See all physician assistant providers in Oklahoma

Medicare billing

Part B allowed, 2024
$9,052
Medicare patients
50
Services billed
126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate47$132,274
Abilify MaintenaAripiprazole12$29,413
RexultiBrexpiprazole11$19,127
TrintellixVortioxetine Hydrobromide12$9,245
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl24$4,614
Aripiprazole90$2,687
Ziprasidone Hcl14$1,936
Trazodone Hcl156$1,248
Duloxetine Hcl69$1,063
Quetiapine Fumarate48$1,042
Bupropion XlBupropion Hcl79$923
Sertraline Hcl99$863
Hydroxyzine Pamoate74$860
Prazosin Hcl43$830
Gabapentin55$737

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$420$132,27447 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$376$48,54023 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,491 physician assistant providers in Oklahoma.

Other physician assistant in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →